Latest News

  • 2017-02-09

    CORBEL staff exchanges: Call for Hosts 2017

    The CORBEL consortium launched its call for hosts for its staff exchanges program. This program is for operational staff from the Research Infrastructures participating in CORBEL to develop operational expertise in four areas – data management, service provision, innovation and ethics – by making short knowledge-exchange visits to other Research Infrastructures (RIs) that are noted for their excellence in the same area. The staff exchanges form an integral part of CORBEL’s WP9 tasks.
    More information here.

  • 2017-01-31

    Launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN)

    Towards better medicines for children: PedCRIN project builds research infrastructure  

    The European Clinical Research Infrastructure Network (ECRIN), partner RI of CORBEL,
    has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN).  
    The three-year project brings together ECRIN and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials.  

    Children represent 20% of the European population and their health is a major societal challenge for Europe and the world, requiring the development of evidence-based paediatric medicines and treatment strategies. Yet, there is a current lack of data specific to neonates, infants and children; over 50% of the medicines used in these groups have not been tested on them specifically, but rather, on adults. This is problematic as neonates/infants/children and adults differ widely in many ways, from their physiology to their metabolic pathways.  

    It is thus important to conduct paediatric trials to increase the knowledge base to develop appropriate, safe and effective health interventions for neonates, infants and children. However, there are various challenges to paediatric studies including dosage and form, recruitment, and many ethical concerns (informed consent, exposure to molecules while still developing, etc.). Therefore, the management of paediatric trials requires the highest level of ethical standards and scientific rigour.
    Through PedCRIN, ECRIN aims to address the above challenges to paediatric trials. This will be achieved by bridging paediatricians and other partners across Europe (and internationally) to combine resources and expertise to conduct and manage robust studies, while minimising risk and protecting the child participants.  
    The three-year PedCRIN project involves five work packages, including project coordination and implementation; definition of the PedCRIN business strategy and governance structure; development of tools specific for paediatric and neonatal trials (trial methodology and (patient-centred) outcome measures, adverse event reporting, bio-sample management, ethical and regulatory database, monitoring, quality and certification); provision of operational support to selected pilot trials, which will be coordinated by ECRIN with the support of national paediatric coordinators hosted by paediatric networks (that currently exist or are being set-up); and communication targeting user communities (including industry partners) and policymakers, and aiming to empower patients and parents.   ‘Through PedCRIN, we hope to develop the necessary tools and capacity to enhance the high quality and ethical standards of multinational paediatric clinical trials. These tools will be tested through the project, refined, and then shared by the European and international scientific community, ensuring that the project gains become sustainable’, said Jacques Demotes, Director General of ECRIN.
    PedCRIN has received funding from the European Union’s Horizon 2020 programme (INFRADEV-3 call) under grant agreement number 731046.  

    Contacts:
    Sabrina Gaber, Communications Officer, ECRIN sabrina.gaber@ecrin.org; +33 1 80 05 86 23
    Begonya Nafria, Patient Advocacy Manager bnafria@sjdhospitalbarcelona.org; + 34 93 600 97 67 ext. 2765
    Joana Claverol Torres, Clinical Research Unit Manager jclaverol@fsjd.org; + 34 93 600 97 33 ext. 70035

  • 2017-01-23

    2nd ENVRIplus call for proposals for multi-disciplinary access to Environmental Research Infrastructures open!

    ENVRIplus (Environmental Research Infrastructures providing shared solutions for Science and Society) is a European Horizon 2020 project bringing together Environmental and Earth System Research Infrastructures, projects and networks together with technical specialist partners to create a more coherent, interdisciplinary and interoperable cluster of Environmental Research Infrastructures across Europe.

    ENVRIplus offers opportunities for interdisciplinary research via free-of-charge, hands-on access to the following European research facilities involved in cross-cutting areas covering the atmospheric, biosphere, marine, and solid earth domain:

    • SMEAR II – Hyytiälä (Finland)
    • OSUR – La Réunion (France)
    • ETNA INGV – Catania (Italy)
    • SOERE-ACBB – Lusignan (France)

    Deadline for submission of applications is February 24, 2017.

    For more information please visit the ENVRIplus website.

  • 2017-01-19

    CORBEL Innovation Office @ BioFIT conference

    On 01 December 2016, Kees de Ruig (EATRIS and CORBEL’s Innovation Office) was part of a panel discussion at the BioFIT conference in Lille with the titel “How can deal-making process be accelerated by standardised contracts and conditions?” Other panelists were Lorraine Sautter (Inserm) and Paul Hermant (Bird & Bird) and the session was chaired by Nicolas Carboni (Conectus).

    From the session it was clear that many Technology Transfer Offices (TTOs) struggle with contracting with external parties. It is not always easy to negotiate terms and conditions, and in order to ensure consistency as well as to improve quality and reduce timelines, the use of templates is highly recommended. Especially in case multiple projects are conducted with different partners in consortia, the use of a Master Research Collaboration Agreement is very instrumental.
    The good news is that TTO’s don’t need to reinvent the wheel; many resources are available including the Lambert template agreements. Additionally, the Innovation Office of CORBEL provides templates and guidance, as well as ad hoc consultancy. The innovation office can be reached at innovation [at] corbel-project.eu; more information can be found on the website.

  • 2016-12-01

    Innovation Helpdesk: new guidelines online!

    The CORBEL Innovation Office Helpdesk, intended to assist Research Infrastructures with collaboration with industry and technology transfer, made available a set of new documents:

    - Compendium on Elements of Collaboration and Licensing Agreements
    - Guidelines for Technology Transfer and Partnering
    - Good Negotiating Practice
    - Features of Intellectual Property
    - Approaches to Life Science Evaluation

    Enjoy reading!

Event Announcements

  • ELIXIR Innovation & SME Forum: Genomics and Health - Global resources for local Innovation

    27. – 28. February 2017

    The next event of the ELIXIR Innovation & SME Forum is scheduled for February 27-28, 2017 in Helsinki (Finland).

    The forum is aimed at the companies that use public bioinformatics resources in their business and would like to further streamline this process. The event is jointly organized by ELIXIR Finland, ELIXIR Estonia and the ELIXIR Hub and is particularly relevant for large and small companies active in the genomics and health domains.
    For more information visit the ELIXIR website.

  • Final Meeting on Patient-level Data Sharing

    27. – 28. March 2017

    The CORBEL patient-level data taskforce helds its final meeting on March 27-28, 2017 in Paris (France). The consensus document on usage of patient-level data as well as the technical solutions for data sharing discussed within this group will be presented.

  • CORBEL @ BIOVISION 2017

    04. – 06. April 2017

    CORBEL, represented by colleagues from BBMRI, EATRIS, ECRIN and ELIXIR, will exhibit at the BIOVISION 2017, taking place April 4-6, 2017 in Lyon (France).

    CORBEL users can obtain 30% reduction of registration costs by using the code CORBELBV17 during registration.

    Background:
    Biovision, the international forum of innovation in health and the life sciences, will unite the global private and public scientific, academic and industrial communities over three days: a unique operational opportunity to accelerate progress in health innovation.  
    The 12th edition of Biovision will host the global health community in Lyon. Continuing to make waves in the international community and centered on salient strategies and pressing global health issues, Biovision will welcome leading personalities and players in research and innovation, among them public and political decision-makers, business and industry leaders and civil society representatives, to promote exchanges, networking, partnerships and investments. 
    This edition of Biovision will encourage cooperative work, presenting participants with new dynamic ways of exchanging and interacting and encouraging project development over a variety of different sessions. 

    Additional info material:
    Call for application
    BIOVISION slide kit

  • 3rd MIUF Meeting

    19. April 2017

    The next MIUF (Medical Infrastructure/Users Forum) meeting takes place April 19, 2017 in Paris (France). More information will be provided soon.

  • Instruct Biennial Structural Biology Meeting 2017

    24. – 26. May 2017

    The 3rd Instruct Biennial Structural Biology Meeting takes place May 24-26, 2017 in Brno (Czech Republic).

    For more information please visit the Instruct website.

  • How European Biological and Medical Sciences Research Infrastructures boost innovation by open access

    20. June 2017

    Organised by CORBEL WP8 Accelerating innovation, the meeting takes place June 20, 2017 in Brussels.

    The purpose of this meeting is to explore how the 11 Biological and Medical Sciences Research Infrastructures (BMS RIs) can stimulate innovation in Europe through providing access to their key assets, such as resources, technologies, data and knowledge. We will showcase the Research Infrastructures and discuss novel models of collaboration with industry. Topics will include:  

        - How resources, technologies, data and knowledge provided by different RIs can address
          industries’ needs optimally    

        - IP strategy in open innovation and new business models   

        - What could be the contribution of Expert Centres, a novel model of public-private
          partnership, to open innovation  

    Target groups: research infrastructures, industry, the European Commission, research groups
                             and other stakeholders from research and innovation fields.

    Please register via mail to christoph.schreiner [at] medunigraz.at. There is no registration fee.

  • CORBEL Mid-Term Review

    22. June 2017

    The CORBEL Mid-Term Review takes place June 22, 2017 in Brussels (Belgium).

  • 2nd CORBEL Annual General Meeting

    25. – 26. October 2017

    SAVE THE DATE: The 2nd CORBEL Annual General Meeting will take place on October 25-26, 2017 in Amsterdam (The Netherlands).

This project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.